The #2 NFL Draft Pick Who Almost Didn't Make It: Robert Gallery on TBI, Ibogaine, and Flow
No Way Out
Outro
Hosts close with thanks, links to resources, and reminders to subscribe and check show notes.
On April 18, 2026, President Trump signed an executive order directing federal agencies to accelerate ibogaine research and expand veteran access. No Way Out recorded this conversation the day before — and it's the orientation event the policy statement isn't.
Robert Gallery was the second overall pick in the 2004 NFL Draft. By 2019, twenty years of head trauma had left him in a daily fog of brain damage, rage, and alcohol, with no clear way forward. He had the brain scan, the neurologist, the hyperbaric chambers. None of it moved the needle. Then he heard veterans talking about ibogaine and flew to Tijuana.
Brian "Ponch" Rivera, Mark "Moose" McGrath, Gallery, and Mark "Slider" Keller — who has personally supported over 400 veterans through ibogaine treatment — cover what reorientation looks like from inside the process. Not the policy. The experience.
They bring the Boyd frame: the flow states Gallery found on the football field, the orientation that collapsed after twenty years of grind and injury and retirement, and what ibogaine started and integration had to finish. Slider explains why he now calls ibogaine an oneirogen with psychedelic side effects — not a psychedelic — and what separates the people who hold their healing from the ones who don't.
Gallery built Athletes for Care to take what the veteran community figured out and bring it to athletes who are still suffering in silence. The executive order just made the conversation easier to have. This episode is the reason it matters.
Guest resources: athletesforcare.org | vetsolutions.org |
John R. Boyd's Conceptual Spiral was originally titled No Way Out. In his own words:
“There is no way out unless we can eliminate the features just cited. Since we don’t know how to do this, we must continue the whirl of reorientation…”
A promotional message for Ember Health. Safe and effective IV ketamine care for individuals seeking relief from depression. Ember Health's evidence-based, partner-oriented, and patient-centered care model, boasting an 84% treatment success rate with 44% of patients reaching depression remission. It also mentions their extensive experience with over 40,000 infusions and treatment of more than 2,500 patients, including veterans, first responders, and individuals with anxiety and PTSD
Stay connected with No Way Out and The Whirl Of ReOrientation
X: @NoWayOutcast · @PonchAGLX · @NoWayOutMoose
Substack: The Whirl Of ReOrientation - www.thewhirl.substack.com
The AI-powered Podcast Player
